Helius Medical Technologies, Inc. (HSDT)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Helius Medical Technologies, Inc. (HSDT) is down 48.8% since the beginning of the year. At $1 per share, HSDT is trading 98.4% below its 52-week high of $93. Investors who bought $1,000 worth of HSDT shares 5 years ago would now be looking at an investment worth $0.

Helius Medical Technologies, Inc. (HSDT) has returned -48.79% so far this year and -99.16% over the past 12 months. Over the last ten years, HSDT has returned -74.19% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Jun 27, 2014, HSDT's average daily return is -0.10%, while the average monthly return is -2.23%.

Historically, 37% of months were positive and 63% were negative. The best month was Feb 2018 with a return of +458.8%, while the worst month was Jun 2025 at -95.6%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.

On a daily basis, HSDT closed higher 42% of trading days. The best single day was Feb 20, 2018 with a return of +472.7%, while the worst single day was Apr 10, 2019 at -66.2%.

Helius Medical Technologies, Inc. has an annualized alpha of -28.88%, beta of 0.70, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since June 30, 2014.

• This stock participated in 227.38% of S&P 500 Index downside but only -132.12% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

HSDT ranks 9 for risk / return — in the bottom 9% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Helius Medical Technologies, Inc. (HSDT) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Helius Medical Technologies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Helius Medical Technologies, Inc. was 100.00%, occurring on Jun 3, 2026. The portfolio has not yet recovered.

The current Helius Medical Technologies, Inc. drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Helius Medical Technologies, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Helius Medical Technologies, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.